Toward Optimum Benefit‐Risk and Reduced Access Lag For Cancer Drugs in Asia: A Global Development Framework Guided by Clinical Pharmacology PrinciplesKarthik Venkatakrishnan, Ashley Milton, Kiyoshi Takeyama et al.|Clinical and Translational Science|2016Cited by 27
Mo1229 Exposure-Response Relationship of Vedolizumab Treatment in Adults With Ulcerative ColitisJonathan French, Marc R. Gastonguay, Maria Rosario et al.|Gastroenterology|2014Cited by 3
Mo1225 Population Pharmacokinetic Modeling of Vedolizumab in Patients With Ulcerative Colitis or Crohn's DiseaseNathanael L. Dirks, Ashley Milton, Maria Rosario et al.|Gastroenterology|2014Cited by 3
Mo1231 Vedolizumab Exposure-Response Relationship During Induction Therapy in Adults With Crohn's DiseaseJonathan French, Marc R. Gastonguay, Ashley Milton et al.|Gastroenterology|2014Cited by 2